search
Back to results

Education for Prevention and Treatment of Frailty (FRAGSALUD)

Primary Purpose

Frailty, Frail Elderly Syndrome

Status
Active
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Health intervention programme: FRAGSALUD
Sponsored by
University of Cadiz
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Frailty focused on measuring Elderly Persons, Aging, Cost-Efficiency Analysis, Health Education

Eligibility Criteria

65 Years - undefined (Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Patients over 65 years of age who present frailty or pre-frailty, assessed using the Fried criteria adapted to Spanish population; Patients belonging to Clinical Management Units participating in the study and who will remain in it for the 15 months of the study; Patients who can come to the Health Center alone or accompanied. Exclusion Criteria: Patients suffering from COPD stage III or IV; Patients suffering from unstable angina; Patients suffering from uncontrolled congestive heart failure, or unstable arrhythmia; Patients who cannot walk alone or with technical aids, such as bedridden people; patients in nursing home; Patients with cognitive impairment; Patients who do not understand Spanish; Patients with allergies to plastic or metal.

Sites / Locations

  • Faculty of Education

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control Group

Intervention Group

Arm Description

Participants who do not receive attention from the Fragsalud program. The control group follows the usual care and preventive measures in Primary Care, according to different protocols implemented and the criteria of nurses and family doctors responsible for their care.

The FRAGSALUD Programme is a multidomain intervention programme, which covers the prevention and treatment of frailty from different aspects, fundamentally from a physical and cognitive aspect and to maintain social integration, although other modifiable factors that are related to the presence of fragility such as hearing impairment, visual deficit or depression.

Outcomes

Primary Outcome Measures

Evaluation of the change of baseline Fried frailty criteria at 6 months
- Fried frailty criteria adapted to the Spanish population: subjects are considered non-frail when no criteria are present, pre-frail if they meet 1 or 2 of the criteria, and frail if they meet 3 to 5 criteria. Fried frailty criteria are divided into 5: Weight loss, Exhaustion, Physical Activity, Walking time, and Muscle weakness.
Evaluation of the change of baseline Fried frailty criteria at 12 months
- Fried frailty criteria adapted to the Spanish population: subjects are considered non-frail when no criteria are present, pre-frail if they meet 1 or 2 of the criteria, and frail if they meet 3 to 5 criteria. Fried frailty criteria are divided into 5: Weight loss, Exhaustion, Physical Activity, Walking time, and Muscle weakness.
Evaluation of the change of baseline weight change at 6 months
Unintentional weight loss of 5% or more in the last year: it is calculated using the difference between the current weight and that recorded in the medical record in the last year. If not available, the criterion is considered to be met if the answer is positive to Have you lost weight in the last year? and Have you lost more than 3 kg in the last year?
Evaluation of the change of baseline weight change at 12 months
Unintentional weight loss of 5% or more in the last year: it is calculated using the difference between the current weight and that recorded in the medical record in the last year. If not available, the criterion is considered to be met if the answer is positive to Have you lost weight in the last year? and Have you lost more than 3 kg in the last year?
Evaluation of the change of baseline exhaustion at 6 months
Self-reported exhaustion or tiredness: they met the criteria if they answered frequently or always in at least one of the 2 questions of the Center for Epidemiologic Studies Depression Scale (CES-D) questionnaire, do I feel that everything I do is an effort? And I don't feel like doing anything?
Evaluation of the change of baseline exhaustion at 12 months
Self-reported exhaustion or tiredness: they met the criteria if they answered frequently or always in at least one of the 2 questions of the Center for Epidemiologic Studies Depression Scale (CES-D) questionnaire, do I feel that everything I do is an effort? And I don't feel like doing anything?
Evaluation of the change of baseline physical activity at 6 months
Based on the reduced version of the Minnesota Leisure Time Activity Questionnaire (VREM) validated in Spanish for this age group, which asks about leisure-time physical activity. The kilocalories (Kcal) per week expended are calculated using a standardized algorithm. This variable is stratified by gender. Men: those with <383 Kcals of physical activity per week meet the frailty criteria. Women: those with <270 Kcals per week meet the criteria for frailty.
Evaluation of the change of baseline physical activity at 12 months
Based on the reduced version of the Minnesota Leisure Time Activity Questionnaire (VREM) validated in Spanish for this age group, which asks about leisure-time physical activity. The kilocalories (Kcal) per week expended are calculated using a standardized algorithm. This variable is stratified by gender. Men: those with <383 Kcals of physical activity per week meet the frailty criteria. Women: those with <270 Kcals per week meet the criteria for frailty.
Evaluation of the change of baseline walking time at 6 months
The results will be stratified by sex and height. Time limit to walk 4.57 meters for frailty, men taller than 1.63 cm: ≥6.4 seconds, all others: ≥7.2 seconds; women with a height over than 1.51 cm: ≥10.5 seconds, the rest: ≥11.2 seconds.
Evaluation of the change of baseline walking time at 12 months
The results will be stratified by sex and height. Time limit to walk 4.57 meters for frailty, men taller than 1.63 cm: ≥6.4 seconds, all others: ≥7.2 seconds; women with a height over than 1.51 cm: ≥10.5 seconds, the rest: ≥11.2 seconds.
Evaluation of the change of baseline muscle weakness at 6 months
The grip strength in the dominant hand will be measured with an arch dynamometer (Jamar® digital hand dynamometer) that expresses the force in kilograms. Those who cannot perform the test or according to the cut-off values meet the criteria: body mass index (BMI) equal to or over than 30 (men ≤15 kg/cm2, women ≤7 kg/cm2); BMI between 25.1 and 29.9 (men ≤13 kg/cm2, women ≤6 kg/cm2), and BMI equal to or less than 25 (men ≤10 kg/cm2, women ≤6 kg/cm2).
Evaluation of the change of baseline muscle weakness at 12 months
The grip strength in the dominant hand will be measured with an arch dynamometer (Jamar® digital hand dynamometer) that expresses the force in kilograms. Those who cannot perform the test or according to the cut-off values meet the criteria: body mass index (BMI) equal to or over than 30 (men ≤15 kg/cm2, women ≤7 kg/cm2); BMI between 25.1 and 29.9 (men ≤13 kg/cm2, women ≤6 kg/cm2), and BMI equal to or less than 25 (men ≤10 kg/cm2, women ≤6 kg/cm2).

Secondary Outcome Measures

Evaluation of the change of baseline Cognitive status at 6 months
- Cognitive status will be evaluated using The Short Portable Mental Status Questionnaire (SPMSQ) which includes 10 items. Depending on the number of errors, participants will be stratified in: 0-2 errors: normal mental functioning 3-4 errors: mild cognitive impairment 5-7 errors: moderate cognitive impairment 8 or more errors: severe cognitive impairment
Evaluation of the change of baseline Cognitive status at 12 months
- Cognitive status will be evaluated using The Short Portable Mental Status Questionnaire (SPMSQ) which includes 10 items. Depending on the number of errors, participants will be stratified in: 0-2 errors: normal mental functioning 3-4 errors: mild cognitive impairment 5-7 errors: moderate cognitive impairment 8 or more errors: severe cognitive impairment
Evaluation of the change of baseline Nutritional status at 6 months
- Nutritional status: the eating pattern will be assessed using the Mini Nutritional Assessment (MNA) test, which is a nutritional assessment and screening method for the elderly population. It consists of two parts: a screening (7 questions), and an evaluation (12 questions). A total score ≥ 24 indicates good nutritional status, between 17-23.5 identifies nutritional risk, and less than 17 the patient presents protein-calorie malnutrition.
Evaluation of the change of baseline Nutritional status at 12 months
- Nutritional status: the eating pattern will be assessed using the Mini Nutritional Assessment (MNA) test, which is a nutritional assessment and screening method for the elderly population. It consists of two parts: a screening (7 questions), and an evaluation (12 questions). A total score ≥ 24 indicates good nutritional status, between 17-23.5 identifies nutritional risk, and less than 17 the patient presents protein-calorie malnutrition.
Evaluation of the change of baseline Emotional state at 6 months
- Emotional state: using the Yesavage geriatric depression scale. It is a questionnaire for depression screening in people over 65 years of age. It consists of 15 questions, each wrong answer scores 1. The cut-off points are: 0-4 normal and 5 or + depression.
Evaluation of the change of baseline Emotional state at 12 months
- Emotional state: using the Yesavage geriatric depression scale. It is a questionnaire for depression screening in people over 65 years of age. It consists of 15 questions, each wrong answer scores 1. The cut-off points are: 0-4 normal and 5 or + depression.
Evaluation of the change of baseline Sleep quality at 6 months
- Self-perceived sleep quality using the Pittsburgh Sleep Quality Index (PSQI), validated in Spanish. 7 components are obtained: subjective quality, sleep latency, sleep duration, "sleep efficiency", sleep disturbances, use of hypnotic medication, daytime dysfunction. The sum of the partial scores generates a total score, which can range from 0-21. According to Buysse et al, a score of 5 would be the cut-off point that would separate subjects who have good sleep quality from those who have poor sleep quality.
Evaluation of the change of baseline Sleep quality at 12 months
- Self-perceived sleep quality using the Pittsburgh Sleep Quality Index (PSQI), validated in Spanish. 7 components are obtained: subjective quality, sleep latency, sleep duration, "sleep efficiency", sleep disturbances, use of hypnotic medication, daytime dysfunction. The sum of the partial scores generates a total score, which can range from 0-21. According to Buysse et al, a score of 5 would be the cut-off point that would separate subjects who have good sleep quality from those who have poor sleep quality.
Evaluation of the change of baseline Social interaction at 6 months
- Social interaction through the Duke-UNC questionnaire of perceived social support, consisting of 11 items and a Likert-type response scale (1-5). The scoring range is between 11 and 55 points. The lower the score, the less support. In the Spanish validation, a cut-off point of <32 was chosen. A score equal to or greater than 32 indicates normal support, while less than 32 indicates low perceived social support.
Evaluation of the change of baseline Social interaction at 12 months
- Social interaction through the Duke-UNC questionnaire of perceived social support, consisting of 11 items and a Likert-type response scale (1-5). The scoring range is between 11 and 55 points. The lower the score, the less support. In the Spanish validation, a cut-off point of <32 was chosen. A score equal to or greater than 32 indicates normal support, while less than 32 indicates low perceived social support.
Evaluation of the change of baseline Health-related Quality of life at 6 months
- Health-related quality of life: the EuroQol-5D-5L questionnaire validated in Spanish will be used, describing five dimensions (mobility, personal care, daily activities, pain/discomfort and anxiety/depression). It also consists of a visual analogue scale (VAS), graduated from 0 to 100 and labeled "worst imaginable health state" and "best imaginable health state", respectively.
Evaluation of the change of baseline Health-related Quality of life at 12 months
- Health-related quality of life: the EuroQol-5D-5L questionnaire validated in Spanish will be used, describing five dimensions (mobility, personal care, daily activities, pain/discomfort and anxiety/depression). It also consists of a visual analogue scale (VAS), graduated from 0 to 100 and labeled "worst imaginable health state" and "best imaginable health state", respectively.
Evaluation of the change of baseline Functional capacity in daily life (Lawton & Brody scale and Barthel index) at 6 months
- Evaluation of functional capacities for personal independence, using the Lawton and Brody scale, which evaluates 8 instrumental activities of daily life in 10 Likert-type items. Depending on the degree of dependence, every item is scored between 0 to 10, with a final puntuation between 0 to 100. Depending on the final score, the degree of dependency is evaluated with the lower the score, the more dependency.
Evaluation of the change of baseline Functional capacity in daily life (Lawton & Brody scale and Barthel index) at 12 months
- Evaluation of functional capacities for personal independence, using the Lawton and Brody scale, which evaluates 8 instrumental activities of daily life in 10 Likert-type items. Depending on the degree of dependence, every item is scored between 0 to 10, with a final puntuation between 0 to 100. Depending on the final score, the degree of dependency is evaluated with the lower the score, the more dependency.
Evaluation of the change of baseline Functional capacity in daily life (Exercise, physical inactivity and sleep) at 6 months
- Assessment of exercise, physical inactivity and sleep that will be carried out using accelerometers for 7 days at the beginning, a year and 15 months. Participants are asked to wear a triaxial accelerometer (GeneActiv, Activinsights Ltd, Kimbolton, Cambs, UK, http://www.geneactiv.org/) on their non-dominant wrist 24 hours a day. The GeneActiv Recorder contains a triaxial MEMS accelerometer with a range of ± 8 g. and a sensitivity ≥ 0.004 g. It records both motion-related acceleration and gravitational acceleration and has linear and equal sensitivity along all three axes (forward/backward, up/down, left/right). This monitor provides the end user with raw accelerometry data. In this study, the accelerometer will be configured at 40 Hz. For data processing, the system developed for the PREDIMEDPLUS study will be used. The data processing is done with an open source package in R, GGIR version 1.5-12.
Evaluation of the change of baseline Functional capacity in daily life (Exercise, physical inactivity and sleep) at 12 months
- Assessment of exercise, physical inactivity and sleep that will be carried out using accelerometers for 7 days at the beginning, a year and 15 months. Participants are asked to wear a triaxial accelerometer (GeneActiv, Activinsights Ltd, Kimbolton, Cambs, UK, http://www.geneactiv.org/) on their non-dominant wrist 24 hours a day. The GeneActiv Recorder contains a triaxial MEMS accelerometer with a range of ± 8 g. and a sensitivity ≥ 0.004 g. It records both motion-related acceleration and gravitational acceleration and has linear and equal sensitivity along all three axes (forward/backward, up/down, left/right). This monitor provides the end user with raw accelerometry data. In this study, the accelerometer will be configured at 40 Hz. For data processing, the system developed for the PREDIMEDPLUS study will be used. The data processing is done with an open source package in R, GGIR version 1.5-12.
Evaluation of the change of baseline Functional capacity in daily life (Balance assessment) at 6 months
- Assessment of balance by means of single-legged support, it will be requested that they remain as long as possible supported by only one of their lower extremities with their arms at the sides of the trunk. The duration of the test will be considered until one of the following conditions is met: a) The support foot changes position, b) The elevated foot touches the ground, c) The arms come off the trunk, and d) When the leg raised touches the supporting limb. The maximum time considered is 30 seconds. The best time of two attempts will be recorded. Based on the results, the subjects will be divided into two groups. Those who reach a time >5 seconds that will be classified as high performance, and with a score ≤ 5 low performance.
Evaluation of the change of baseline Functional capacity in daily life (Balance assessment) at 12 months
- Assessment of balance by means of single-legged support, it will be requested that they remain as long as possible supported by only one of their lower extremities with their arms at the sides of the trunk. The duration of the test will be considered until one of the following conditions is met: a) The support foot changes position, b) The elevated foot touches the ground, c) The arms come off the trunk, and d) When the leg raised touches the supporting limb. The maximum time considered is 30 seconds. The best time of two attempts will be recorded. Based on the results, the subjects will be divided into two groups. Those who reach a time >5 seconds that will be classified as high performance, and with a score ≤ 5 low performance.
Evaluation of the change of baseline Adverse outcomes at 6 months
- Evaluate the rates of falls, fractures due to falls, hospital admissions, days of hospital admission, interventions, inclusions in home care programs, institutionalizations in residences and deaths. The evaluation will be carried out by consulting the clinical health history and by direct questioning.
Evaluation of the change of baseline Adverse outcomes at 12 months
- Evaluate the rates of falls, fractures due to falls, hospital admissions, days of hospital admission, interventions, inclusions in home care programs, institutionalizations in residences and deaths. The evaluation will be carried out by consulting the clinical health history and by direct questioning.
Evaluation of the change of baseline self perceived confidence at 6 months
- Evaluation of self-efficacy using the General Self-Efficacy Scale. Consisting of 10 items on a Likert scale ranging from 1 (not at all) to 4 (a lot), the scale assesses the degree to which they perceive self-confidence when managing general activities in daily life. It was developed by Sherer et al., it is validated in Spanish.
Evaluation of the change of baseline self perceived confidence at 12 months
- Evaluation of self-efficacy using the General Self-Efficacy Scale. Consisting of 10 items on a Likert scale ranging from 1 (not at all) to 4 (a lot), the scale assesses the degree to which they perceive self-confidence when managing general activities in daily life. It was developed by Sherer et al., it is validated in Spanish.
Evaluation of the change of baseline Cost-utility analysis at 6 months
- Cost-utility analysis, following the recommendations of the proposed guide for economic evaluation applied to health technologies. Healthcare resources: a) the consumption of healthcare services associated with falls will be analysed: hospital admissions, Primary Care medical and nursing consultations, Primary Care medical and nursing visits at home (during regular hours), emergency medical visits for Primary Care Primary at home, medical consultations in the Hospital (UGC Traumatology and Rehabilitation), emergency medical consultations in the Hospital Center, medication and complementary tests; b) the consumption of services in general will also be analysed: visits to primary nursing and medical care, visits to primary nursing and medical care, visits to the emergency department, visits to medical specialties, hospital admissions and surgical interventions.
Evaluation of the change of baseline Cost-utility analysis at 12 months
- Cost-utility analysis, following the recommendations of the proposed guide for economic evaluation applied to health technologies. Healthcare resources: a) the consumption of healthcare services associated with falls will be analysed: hospital admissions, Primary Care medical and nursing consultations, Primary Care medical and nursing visits at home (during regular hours), emergency medical visits for Primary Care Primary at home, medical consultations in the Hospital (UGC Traumatology and Rehabilitation), emergency medical consultations in the Hospital Center, medication and complementary tests; b) the consumption of services in general will also be analysed: visits to primary nursing and medical care, visits to primary nursing and medical care, visits to the emergency department, visits to medical specialties, hospital admissions and surgical interventions.
Evaluation of the change of Intervention satisfaction assessed by CSQ-8 at 6 months
- Evaluation of satisfaction with the intervention: the CSQ-8 (Client Satisfaction Questionnaire) will be used, with 8 questions evaluated according to a 4-point Likert-type scale, with specific cut-off points for each of the items. It has been validated in a Spanish-speaking population.
Evaluation of the change of Intervention satisfaction assessed by CSQ-8 at 12 months
- Evaluation of satisfaction with the intervention: the CSQ-8 (Client Satisfaction Questionnaire) will be used, with 8 questions evaluated according to a 4-point Likert-type scale, with specific cut-off points for each of the items. It has been validated in a Spanish-speaking population.
Change in Sociodemographic data at 6 months
Date of birth, sex, marital status, cohabitation, educational level, amount of pension income.
Change in Sociodemographic data at 12 months
Date of birth, sex, marital status, cohabitation, educational level, amount of pension income.
Change in Medical data at 6 months
Number and type of chronic pathologies (comorbidities). Number of different medications you take daily and type of medication.
Change in Medical data at 12 months
Number and type of chronic pathologies (comorbidities). Number of different medications you take daily and type of medication.
Assessed changes from Baseline Blood Sample (Hematocrit) at 6 months
1. Hematocrit (%)
Assessed changes from Baseline Blood Sample (Hematocrit) at 12months
1. Hematocrit (%)
Assessed changes from Baseline Hemoglobin, protein and albumin sample at 6 months
2. Hemoglobin (g/dL) 3. Total protein (g/dL) 4. Serum Albumin (g/dL)
Assessed changes from Baseline Hemoglobin, protein and albumin sample at 12 months
2. Hemoglobin (g/dL) 3. Total protein (g/dL) 4. Serum Albumin (g/dL)
Assessed changes from Baseline lipids, and plasma creatinine sample at 6 months
5. Lipid profile (mg/dL) 6. Plasma creatinine (mg/dL)
Assessed changes from Baseline lipids, and plasma creatinine sample at 12 months
5. Lipid profile (mg/dL) 6. Plasma creatinine (mg/dL)
Assessed changes from Baseline Blood Sample (Glycosylated hemoglobin) at 6 months
7. Glycosylated hemoglobin (A1C)
Assessed changes from Baseline Blood Sample (Glycosylated hemoglobin) at 12 months
7. Glycosylated hemoglobin (A1C)
Assessed changes from Baseline Biological variables: Weight at 6 months
1. Weight (kilograms)
Assessed changes from Baseline Biological variables: Weight at 12months
1. Weight (kilograms)
Assessed changes from Baseline Biological variables: Height at 6 months
2. Height (meters)
Assessed changes from Baseline Biological variables: Height at 12 months
2. Height (meters)
Assessed changes from Baseline Biological variables: Body Mass Index at 6 months
3. Body Mass Index (kg/m^2)
Assessed changes from Baseline Biological variables: Body Mass Index at 12 months
3. Body Mass Index (kg/m^2)
Assessed changes from Baseline Biological variables: Waist circunference at 6 months
4. Waist circunference (cm)
Assessed changes from Baseline Biological variables: Waist circunference at 12 months
4. Waist circunference (cm)
Assessed changes from Baseline Biological variables: Blood pressure at 6 months
5. Systolic and diastolic Blood pressure (mmHg)
Assessed changes from Baseline Biological variables: Blood pressure at 12 months
5. Systolic and diastolic Blood pressure (mmHg)
Assessed changes from Baseline Smoking and alcohol habits
Number of cigarettes per day Number of alcoholic drinks per day
Assessed changes from Baseline Smoking and alcohol habits
Number of cigarettes per day Number of alcoholic drinks per day

Full Information

First Posted
February 9, 2022
Last Updated
November 8, 2022
Sponsor
University of Cadiz
Collaborators
University of Malaga, Instituto de investigación e innovación biomédica de Cádiz
search

1. Study Identification

Unique Protocol Identification Number
NCT05610605
Brief Title
Education for Prevention and Treatment of Frailty
Acronym
FRAGSALUD
Official Title
Randomized Clinical Trial to Assess the Efficacy of an Educational Programme for Prevention and Treatment of Frailty in Older Adults Living in the Community: FRAGSALUD Programme
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 30, 2022 (Actual)
Primary Completion Date
December 1, 2022 (Anticipated)
Study Completion Date
December 31, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Cadiz
Collaborators
University of Malaga, Instituto de investigación e innovación biomédica de Cádiz

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Frailty is a condition with a high prevalence in older adults, leading to higher vulnerability and increasing the risk of adverse health outcomes and disabilities. The aging of the population in Spain is accelerating quickly, consequently, it is necessary to advise the population on the appropriate path to healthy aging, free of fragility and their secondary problems.
Detailed Description
To evaluate the efficacy and efficiency of a Fragsalud program for the prevention and multifactorial treatment of frailty in people over 65 years of age living in the community compared to the usual treatment. Material and methods: A Single blind randomized, two-arm clinical trial; control group and intervention group, multicenter, with 15 months of follow-up, with evaluations blinded at the beginning, and in the follow-up at 12 and 15 months. A recruitment of 196 people over 65 years of age with criteria of pre-frailty or frailty according to Fried's criteria. The Fragsalud education program will be taught in the intervention group; while control group will follow the usual health care. The evolution of the criteria of frailty, cognitive state, eating pattern, emotional state, quality of sleep, perceived social support, quality of life, functional capacity in daily life, adverse results, assessment of self-efficacy and cost-utility analysis variables will be evaluated. Possible confounding factors such as sociodemographic variables, comorbidity and polymedication will be controlled. Intention-to-treat analysis will be performed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Frailty, Frail Elderly Syndrome
Keywords
Elderly Persons, Aging, Cost-Efficiency Analysis, Health Education

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
196 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control Group
Arm Type
No Intervention
Arm Description
Participants who do not receive attention from the Fragsalud program. The control group follows the usual care and preventive measures in Primary Care, according to different protocols implemented and the criteria of nurses and family doctors responsible for their care.
Arm Title
Intervention Group
Arm Type
Experimental
Arm Description
The FRAGSALUD Programme is a multidomain intervention programme, which covers the prevention and treatment of frailty from different aspects, fundamentally from a physical and cognitive aspect and to maintain social integration, although other modifiable factors that are related to the presence of fragility such as hearing impairment, visual deficit or depression.
Intervention Type
Other
Intervention Name(s)
Health intervention programme: FRAGSALUD
Intervention Description
The FRAGSALUD Program consists in two parts, a first part of health education that will be taught in a group in four sessions, and a second part of individual treatment and follow-up, individual consultations will have a bimonthly periodicity until reaching one year, at which time that the program ends and a final evaluation will be carried out to assess whether the changes are maintained 15 months after the start.
Primary Outcome Measure Information:
Title
Evaluation of the change of baseline Fried frailty criteria at 6 months
Description
- Fried frailty criteria adapted to the Spanish population: subjects are considered non-frail when no criteria are present, pre-frail if they meet 1 or 2 of the criteria, and frail if they meet 3 to 5 criteria. Fried frailty criteria are divided into 5: Weight loss, Exhaustion, Physical Activity, Walking time, and Muscle weakness.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Fried frailty criteria at 12 months
Description
- Fried frailty criteria adapted to the Spanish population: subjects are considered non-frail when no criteria are present, pre-frail if they meet 1 or 2 of the criteria, and frail if they meet 3 to 5 criteria. Fried frailty criteria are divided into 5: Weight loss, Exhaustion, Physical Activity, Walking time, and Muscle weakness.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline weight change at 6 months
Description
Unintentional weight loss of 5% or more in the last year: it is calculated using the difference between the current weight and that recorded in the medical record in the last year. If not available, the criterion is considered to be met if the answer is positive to Have you lost weight in the last year? and Have you lost more than 3 kg in the last year?
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline weight change at 12 months
Description
Unintentional weight loss of 5% or more in the last year: it is calculated using the difference between the current weight and that recorded in the medical record in the last year. If not available, the criterion is considered to be met if the answer is positive to Have you lost weight in the last year? and Have you lost more than 3 kg in the last year?
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline exhaustion at 6 months
Description
Self-reported exhaustion or tiredness: they met the criteria if they answered frequently or always in at least one of the 2 questions of the Center for Epidemiologic Studies Depression Scale (CES-D) questionnaire, do I feel that everything I do is an effort? And I don't feel like doing anything?
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline exhaustion at 12 months
Description
Self-reported exhaustion or tiredness: they met the criteria if they answered frequently or always in at least one of the 2 questions of the Center for Epidemiologic Studies Depression Scale (CES-D) questionnaire, do I feel that everything I do is an effort? And I don't feel like doing anything?
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline physical activity at 6 months
Description
Based on the reduced version of the Minnesota Leisure Time Activity Questionnaire (VREM) validated in Spanish for this age group, which asks about leisure-time physical activity. The kilocalories (Kcal) per week expended are calculated using a standardized algorithm. This variable is stratified by gender. Men: those with <383 Kcals of physical activity per week meet the frailty criteria. Women: those with <270 Kcals per week meet the criteria for frailty.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline physical activity at 12 months
Description
Based on the reduced version of the Minnesota Leisure Time Activity Questionnaire (VREM) validated in Spanish for this age group, which asks about leisure-time physical activity. The kilocalories (Kcal) per week expended are calculated using a standardized algorithm. This variable is stratified by gender. Men: those with <383 Kcals of physical activity per week meet the frailty criteria. Women: those with <270 Kcals per week meet the criteria for frailty.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline walking time at 6 months
Description
The results will be stratified by sex and height. Time limit to walk 4.57 meters for frailty, men taller than 1.63 cm: ≥6.4 seconds, all others: ≥7.2 seconds; women with a height over than 1.51 cm: ≥10.5 seconds, the rest: ≥11.2 seconds.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline walking time at 12 months
Description
The results will be stratified by sex and height. Time limit to walk 4.57 meters for frailty, men taller than 1.63 cm: ≥6.4 seconds, all others: ≥7.2 seconds; women with a height over than 1.51 cm: ≥10.5 seconds, the rest: ≥11.2 seconds.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline muscle weakness at 6 months
Description
The grip strength in the dominant hand will be measured with an arch dynamometer (Jamar® digital hand dynamometer) that expresses the force in kilograms. Those who cannot perform the test or according to the cut-off values meet the criteria: body mass index (BMI) equal to or over than 30 (men ≤15 kg/cm2, women ≤7 kg/cm2); BMI between 25.1 and 29.9 (men ≤13 kg/cm2, women ≤6 kg/cm2), and BMI equal to or less than 25 (men ≤10 kg/cm2, women ≤6 kg/cm2).
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline muscle weakness at 12 months
Description
The grip strength in the dominant hand will be measured with an arch dynamometer (Jamar® digital hand dynamometer) that expresses the force in kilograms. Those who cannot perform the test or according to the cut-off values meet the criteria: body mass index (BMI) equal to or over than 30 (men ≤15 kg/cm2, women ≤7 kg/cm2); BMI between 25.1 and 29.9 (men ≤13 kg/cm2, women ≤6 kg/cm2), and BMI equal to or less than 25 (men ≤10 kg/cm2, women ≤6 kg/cm2).
Time Frame
Preintervention/Postintervention (0 and 12 months)
Secondary Outcome Measure Information:
Title
Evaluation of the change of baseline Cognitive status at 6 months
Description
- Cognitive status will be evaluated using The Short Portable Mental Status Questionnaire (SPMSQ) which includes 10 items. Depending on the number of errors, participants will be stratified in: 0-2 errors: normal mental functioning 3-4 errors: mild cognitive impairment 5-7 errors: moderate cognitive impairment 8 or more errors: severe cognitive impairment
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Cognitive status at 12 months
Description
- Cognitive status will be evaluated using The Short Portable Mental Status Questionnaire (SPMSQ) which includes 10 items. Depending on the number of errors, participants will be stratified in: 0-2 errors: normal mental functioning 3-4 errors: mild cognitive impairment 5-7 errors: moderate cognitive impairment 8 or more errors: severe cognitive impairment
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Nutritional status at 6 months
Description
- Nutritional status: the eating pattern will be assessed using the Mini Nutritional Assessment (MNA) test, which is a nutritional assessment and screening method for the elderly population. It consists of two parts: a screening (7 questions), and an evaluation (12 questions). A total score ≥ 24 indicates good nutritional status, between 17-23.5 identifies nutritional risk, and less than 17 the patient presents protein-calorie malnutrition.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Nutritional status at 12 months
Description
- Nutritional status: the eating pattern will be assessed using the Mini Nutritional Assessment (MNA) test, which is a nutritional assessment and screening method for the elderly population. It consists of two parts: a screening (7 questions), and an evaluation (12 questions). A total score ≥ 24 indicates good nutritional status, between 17-23.5 identifies nutritional risk, and less than 17 the patient presents protein-calorie malnutrition.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Emotional state at 6 months
Description
- Emotional state: using the Yesavage geriatric depression scale. It is a questionnaire for depression screening in people over 65 years of age. It consists of 15 questions, each wrong answer scores 1. The cut-off points are: 0-4 normal and 5 or + depression.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Emotional state at 12 months
Description
- Emotional state: using the Yesavage geriatric depression scale. It is a questionnaire for depression screening in people over 65 years of age. It consists of 15 questions, each wrong answer scores 1. The cut-off points are: 0-4 normal and 5 or + depression.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Sleep quality at 6 months
Description
- Self-perceived sleep quality using the Pittsburgh Sleep Quality Index (PSQI), validated in Spanish. 7 components are obtained: subjective quality, sleep latency, sleep duration, "sleep efficiency", sleep disturbances, use of hypnotic medication, daytime dysfunction. The sum of the partial scores generates a total score, which can range from 0-21. According to Buysse et al, a score of 5 would be the cut-off point that would separate subjects who have good sleep quality from those who have poor sleep quality.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Sleep quality at 12 months
Description
- Self-perceived sleep quality using the Pittsburgh Sleep Quality Index (PSQI), validated in Spanish. 7 components are obtained: subjective quality, sleep latency, sleep duration, "sleep efficiency", sleep disturbances, use of hypnotic medication, daytime dysfunction. The sum of the partial scores generates a total score, which can range from 0-21. According to Buysse et al, a score of 5 would be the cut-off point that would separate subjects who have good sleep quality from those who have poor sleep quality.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Social interaction at 6 months
Description
- Social interaction through the Duke-UNC questionnaire of perceived social support, consisting of 11 items and a Likert-type response scale (1-5). The scoring range is between 11 and 55 points. The lower the score, the less support. In the Spanish validation, a cut-off point of <32 was chosen. A score equal to or greater than 32 indicates normal support, while less than 32 indicates low perceived social support.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Social interaction at 12 months
Description
- Social interaction through the Duke-UNC questionnaire of perceived social support, consisting of 11 items and a Likert-type response scale (1-5). The scoring range is between 11 and 55 points. The lower the score, the less support. In the Spanish validation, a cut-off point of <32 was chosen. A score equal to or greater than 32 indicates normal support, while less than 32 indicates low perceived social support.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Health-related Quality of life at 6 months
Description
- Health-related quality of life: the EuroQol-5D-5L questionnaire validated in Spanish will be used, describing five dimensions (mobility, personal care, daily activities, pain/discomfort and anxiety/depression). It also consists of a visual analogue scale (VAS), graduated from 0 to 100 and labeled "worst imaginable health state" and "best imaginable health state", respectively.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Health-related Quality of life at 12 months
Description
- Health-related quality of life: the EuroQol-5D-5L questionnaire validated in Spanish will be used, describing five dimensions (mobility, personal care, daily activities, pain/discomfort and anxiety/depression). It also consists of a visual analogue scale (VAS), graduated from 0 to 100 and labeled "worst imaginable health state" and "best imaginable health state", respectively.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Functional capacity in daily life (Lawton & Brody scale and Barthel index) at 6 months
Description
- Evaluation of functional capacities for personal independence, using the Lawton and Brody scale, which evaluates 8 instrumental activities of daily life in 10 Likert-type items. Depending on the degree of dependence, every item is scored between 0 to 10, with a final puntuation between 0 to 100. Depending on the final score, the degree of dependency is evaluated with the lower the score, the more dependency.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Functional capacity in daily life (Lawton & Brody scale and Barthel index) at 12 months
Description
- Evaluation of functional capacities for personal independence, using the Lawton and Brody scale, which evaluates 8 instrumental activities of daily life in 10 Likert-type items. Depending on the degree of dependence, every item is scored between 0 to 10, with a final puntuation between 0 to 100. Depending on the final score, the degree of dependency is evaluated with the lower the score, the more dependency.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Functional capacity in daily life (Exercise, physical inactivity and sleep) at 6 months
Description
- Assessment of exercise, physical inactivity and sleep that will be carried out using accelerometers for 7 days at the beginning, a year and 15 months. Participants are asked to wear a triaxial accelerometer (GeneActiv, Activinsights Ltd, Kimbolton, Cambs, UK, http://www.geneactiv.org/) on their non-dominant wrist 24 hours a day. The GeneActiv Recorder contains a triaxial MEMS accelerometer with a range of ± 8 g. and a sensitivity ≥ 0.004 g. It records both motion-related acceleration and gravitational acceleration and has linear and equal sensitivity along all three axes (forward/backward, up/down, left/right). This monitor provides the end user with raw accelerometry data. In this study, the accelerometer will be configured at 40 Hz. For data processing, the system developed for the PREDIMEDPLUS study will be used. The data processing is done with an open source package in R, GGIR version 1.5-12.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Functional capacity in daily life (Exercise, physical inactivity and sleep) at 12 months
Description
- Assessment of exercise, physical inactivity and sleep that will be carried out using accelerometers for 7 days at the beginning, a year and 15 months. Participants are asked to wear a triaxial accelerometer (GeneActiv, Activinsights Ltd, Kimbolton, Cambs, UK, http://www.geneactiv.org/) on their non-dominant wrist 24 hours a day. The GeneActiv Recorder contains a triaxial MEMS accelerometer with a range of ± 8 g. and a sensitivity ≥ 0.004 g. It records both motion-related acceleration and gravitational acceleration and has linear and equal sensitivity along all three axes (forward/backward, up/down, left/right). This monitor provides the end user with raw accelerometry data. In this study, the accelerometer will be configured at 40 Hz. For data processing, the system developed for the PREDIMEDPLUS study will be used. The data processing is done with an open source package in R, GGIR version 1.5-12.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Functional capacity in daily life (Balance assessment) at 6 months
Description
- Assessment of balance by means of single-legged support, it will be requested that they remain as long as possible supported by only one of their lower extremities with their arms at the sides of the trunk. The duration of the test will be considered until one of the following conditions is met: a) The support foot changes position, b) The elevated foot touches the ground, c) The arms come off the trunk, and d) When the leg raised touches the supporting limb. The maximum time considered is 30 seconds. The best time of two attempts will be recorded. Based on the results, the subjects will be divided into two groups. Those who reach a time >5 seconds that will be classified as high performance, and with a score ≤ 5 low performance.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Functional capacity in daily life (Balance assessment) at 12 months
Description
- Assessment of balance by means of single-legged support, it will be requested that they remain as long as possible supported by only one of their lower extremities with their arms at the sides of the trunk. The duration of the test will be considered until one of the following conditions is met: a) The support foot changes position, b) The elevated foot touches the ground, c) The arms come off the trunk, and d) When the leg raised touches the supporting limb. The maximum time considered is 30 seconds. The best time of two attempts will be recorded. Based on the results, the subjects will be divided into two groups. Those who reach a time >5 seconds that will be classified as high performance, and with a score ≤ 5 low performance.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Adverse outcomes at 6 months
Description
- Evaluate the rates of falls, fractures due to falls, hospital admissions, days of hospital admission, interventions, inclusions in home care programs, institutionalizations in residences and deaths. The evaluation will be carried out by consulting the clinical health history and by direct questioning.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Adverse outcomes at 12 months
Description
- Evaluate the rates of falls, fractures due to falls, hospital admissions, days of hospital admission, interventions, inclusions in home care programs, institutionalizations in residences and deaths. The evaluation will be carried out by consulting the clinical health history and by direct questioning.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline self perceived confidence at 6 months
Description
- Evaluation of self-efficacy using the General Self-Efficacy Scale. Consisting of 10 items on a Likert scale ranging from 1 (not at all) to 4 (a lot), the scale assesses the degree to which they perceive self-confidence when managing general activities in daily life. It was developed by Sherer et al., it is validated in Spanish.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline self perceived confidence at 12 months
Description
- Evaluation of self-efficacy using the General Self-Efficacy Scale. Consisting of 10 items on a Likert scale ranging from 1 (not at all) to 4 (a lot), the scale assesses the degree to which they perceive self-confidence when managing general activities in daily life. It was developed by Sherer et al., it is validated in Spanish.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of baseline Cost-utility analysis at 6 months
Description
- Cost-utility analysis, following the recommendations of the proposed guide for economic evaluation applied to health technologies. Healthcare resources: a) the consumption of healthcare services associated with falls will be analysed: hospital admissions, Primary Care medical and nursing consultations, Primary Care medical and nursing visits at home (during regular hours), emergency medical visits for Primary Care Primary at home, medical consultations in the Hospital (UGC Traumatology and Rehabilitation), emergency medical consultations in the Hospital Center, medication and complementary tests; b) the consumption of services in general will also be analysed: visits to primary nursing and medical care, visits to primary nursing and medical care, visits to the emergency department, visits to medical specialties, hospital admissions and surgical interventions.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of baseline Cost-utility analysis at 12 months
Description
- Cost-utility analysis, following the recommendations of the proposed guide for economic evaluation applied to health technologies. Healthcare resources: a) the consumption of healthcare services associated with falls will be analysed: hospital admissions, Primary Care medical and nursing consultations, Primary Care medical and nursing visits at home (during regular hours), emergency medical visits for Primary Care Primary at home, medical consultations in the Hospital (UGC Traumatology and Rehabilitation), emergency medical consultations in the Hospital Center, medication and complementary tests; b) the consumption of services in general will also be analysed: visits to primary nursing and medical care, visits to primary nursing and medical care, visits to the emergency department, visits to medical specialties, hospital admissions and surgical interventions.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Evaluation of the change of Intervention satisfaction assessed by CSQ-8 at 6 months
Description
- Evaluation of satisfaction with the intervention: the CSQ-8 (Client Satisfaction Questionnaire) will be used, with 8 questions evaluated according to a 4-point Likert-type scale, with specific cut-off points for each of the items. It has been validated in a Spanish-speaking population.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Evaluation of the change of Intervention satisfaction assessed by CSQ-8 at 12 months
Description
- Evaluation of satisfaction with the intervention: the CSQ-8 (Client Satisfaction Questionnaire) will be used, with 8 questions evaluated according to a 4-point Likert-type scale, with specific cut-off points for each of the items. It has been validated in a Spanish-speaking population.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Change in Sociodemographic data at 6 months
Description
Date of birth, sex, marital status, cohabitation, educational level, amount of pension income.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Change in Sociodemographic data at 12 months
Description
Date of birth, sex, marital status, cohabitation, educational level, amount of pension income.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Change in Medical data at 6 months
Description
Number and type of chronic pathologies (comorbidities). Number of different medications you take daily and type of medication.
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Change in Medical data at 12 months
Description
Number and type of chronic pathologies (comorbidities). Number of different medications you take daily and type of medication.
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline Blood Sample (Hematocrit) at 6 months
Description
1. Hematocrit (%)
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline Blood Sample (Hematocrit) at 12months
Description
1. Hematocrit (%)
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline Hemoglobin, protein and albumin sample at 6 months
Description
2. Hemoglobin (g/dL) 3. Total protein (g/dL) 4. Serum Albumin (g/dL)
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline Hemoglobin, protein and albumin sample at 12 months
Description
2. Hemoglobin (g/dL) 3. Total protein (g/dL) 4. Serum Albumin (g/dL)
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline lipids, and plasma creatinine sample at 6 months
Description
5. Lipid profile (mg/dL) 6. Plasma creatinine (mg/dL)
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline lipids, and plasma creatinine sample at 12 months
Description
5. Lipid profile (mg/dL) 6. Plasma creatinine (mg/dL)
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline Blood Sample (Glycosylated hemoglobin) at 6 months
Description
7. Glycosylated hemoglobin (A1C)
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline Blood Sample (Glycosylated hemoglobin) at 12 months
Description
7. Glycosylated hemoglobin (A1C)
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline Biological variables: Weight at 6 months
Description
1. Weight (kilograms)
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline Biological variables: Weight at 12months
Description
1. Weight (kilograms)
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline Biological variables: Height at 6 months
Description
2. Height (meters)
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline Biological variables: Height at 12 months
Description
2. Height (meters)
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline Biological variables: Body Mass Index at 6 months
Description
3. Body Mass Index (kg/m^2)
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline Biological variables: Body Mass Index at 12 months
Description
3. Body Mass Index (kg/m^2)
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline Biological variables: Waist circunference at 6 months
Description
4. Waist circunference (cm)
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline Biological variables: Waist circunference at 12 months
Description
4. Waist circunference (cm)
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline Biological variables: Blood pressure at 6 months
Description
5. Systolic and diastolic Blood pressure (mmHg)
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline Biological variables: Blood pressure at 12 months
Description
5. Systolic and diastolic Blood pressure (mmHg)
Time Frame
Preintervention/Postintervention (0 and 12 months)
Title
Assessed changes from Baseline Smoking and alcohol habits
Description
Number of cigarettes per day Number of alcoholic drinks per day
Time Frame
Preintervention/Postintervention (0 and 6 months)
Title
Assessed changes from Baseline Smoking and alcohol habits
Description
Number of cigarettes per day Number of alcoholic drinks per day
Time Frame
Preintervention/Postintervention (0 and 12 months)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Patients over 65 years of age who present frailty or pre-frailty, assessed using the Fried criteria adapted to Spanish population; Patients belonging to Clinical Management Units participating in the study and who will remain in it for the 15 months of the study; Patients who can come to the Health Center alone or accompanied. Exclusion Criteria: Patients suffering from COPD stage III or IV; Patients suffering from unstable angina; Patients suffering from uncontrolled congestive heart failure, or unstable arrhythmia; Patients who cannot walk alone or with technical aids, such as bedridden people; patients in nursing home; Patients with cognitive impairment; Patients who do not understand Spanish; Patients with allergies to plastic or metal.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
María Ángeles Vázquez Sanchez, PhD
Organizational Affiliation
Universidad de Málaga
Official's Role
Principal Investigator
Facility Information:
Facility Name
Faculty of Education
City
Puerto Real
State/Province
Cádiz
ZIP/Postal Code
11519
Country
Spain

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Education for Prevention and Treatment of Frailty

We'll reach out to this number within 24 hrs